Service

 

Our (e)Books and (e)Journals

IOS Press serves the information needs of scientific and medical communities worldwide. See what's new and browse our books and journals to learn more.

Service

 

Vacancy: Marketing Communications Manager – Computer Science and AI Portfolios

May 22, 2019 - We are seeking candidates for our marketing department to fill a position as marketing communications manager for journals and books in the computer science and AI portfolios.

May 22, 2019

Saskia Meeuwsen-van Wijngaarden promoted to Head of Marketing

May 1, 2019 - As of May 1st, Saskia Meeuwsen-van Wijngaarden will be Head of Marketing. With her fresh energy, good ideas and dedication she will lead the team in its mission of increasing publications’ reach and impact, facilitating greater efficiency and enhancing use of resources and talents.

May 1, 2019

Tissue Engineering Applications Combining Biomaterial Scaffolds with Stem Cells Will Facilitate Delivery of Targeted Therapies

April 24, 2019 - Amsterdam, NL – StemJournal, a new open access, peer-reviewed journal published by IOS Press, announces publication of its inaugural article, “Combining Stem Cells and Biomaterial Scaffolds for Constructing Tissues and Cell Delivery” by Stephanie M. Willerth, PhD, and Shelly E. Sakiyama-Elbert, PhD. This timely overview of the available biomaterials for directing stem cell differentiation as a means of producing replacements for diseased or damaged tissues is a comprehensive update of the classic review published in StemBook in 2008.

April 24, 2019

When Designing Clinical Trials for Huntington’s Disease, First Ask the Experts: The Patients

April 23, 2019 - Amsterdam, NL – Progress in understanding the genetic mutation responsible for Huntington's disease (HD) and at least some molecular underpinnings of the disease has resulted in a new era of clinical testing of potential treatments. How best to design clinical trials in which HD patients are willing to participate and comply is a question faced by researchers. For that reason, investigators in the Perelman School of Medicine at the University of Pennsylvania (Penn) surveyed HD patients at different stages of the disease about their attitudes and treatment goals. The results, published in the Journal of Huntington's Disease, should be useful for designing future clinical trials of gene therapies for HD and other genetic disorders.

April 23, 2019